107 results
Page 3 of 6
6-K
EX-99.1
fyw7zvfco7
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
EX-99.1
jkb y5ufl348nl7zw
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
qbmsom bi
21 Apr 15
Business combination disclosure
12:00am
425
np4d0nyyr
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
24kp sud76qax11b
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
6-K
gam3f
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
noh8h7zjgh0ioyju707j
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
6hh659 0b
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
x0wrphdnzn8xkfjy60m
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
em6wmx
3 Jul 14
Current report (foreign)
12:00am
6-K
cldbwy6ewxxvmxi oral
18 Jun 14
Current report (foreign)
12:00am
6-K
EX-99.1
nvjv9r57z25o7b3f
2 Jun 14
Appoints Sigurdur Olafsson As President and Ceo of Newly Established Global Generic Medicines Group
12:00am
6-K
EX-99.1
wwazswf
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am
6-K
umzmd
13 Mar 14
Live Filing
12:00am
6-K
EX-99.1
ub113g r3
13 Mar 14
Live Filing
12:00am
6-K
EX-99.1
plyca278wrfjh 3gwk6
29 Jan 14
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mL
12:00am
6-K
EX-99.1
2c88pm0kj
4 Dec 13
Teva and Takeda Announce Development and Distribution Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
12:00am
6-K
EX-99.1
4l1tnuxuoiy1y
4 Dec 13
Live Filing
12:00am